Search results for "thyroid."

showing 10 items of 797 documents

Mid-region parathyroid hormone-related protein (PTHrP) and gene expression of MDA-MB231 breast cancer cells.

2007

Abstract We have previously shown that PTHrP(38–94) amide restrains growth and invasion in vitro, causes striking toxicity and accelerates death of some breast cancer cell lines, the most responsive being MDA-MB231, for which tumorigenesis was also attenuated in vivo. We have also demonstrated that mid-region PTHrP gains access to the nuclear compartment of these cells and displays DNA-binding properties in vitro by recognizing targets in both cellular chromatin and isolated oligonucleotides. Here, we examined whether PTHrP(38–94) amide was able to modulate gene expression of MDA-MB231 cells, employing a combination of conventional, differential display and semi-quantitative multiplex PCR t…

Differential displayParathyroid hormone-related proteinChemistryClinical BiochemistryMolecular Sequence DataParathyroid Hormone-Related ProteinBreast Neoplasmsmedicine.disease_causeBiochemistryIn vitroChromatinGene Expression Regulation NeoplasticCell Line TumorGene expressionmedicineCancer researchCytotoxic T cellHumansCarcinogenesisMolecular BiologyReprogrammingBiomarkersChromosomes Human Pair 8Biological chemistry
researchProduct

Diffuse Lipomatosis of the Thyroid Gland

2021

Diffuse LipomatosisPathologymedicine.medical_specialtymedicine.anatomical_structurebusiness.industryThyroidMedicineGeneral MedicinebusinessThe American Surgeon
researchProduct

Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment

2022

PURPOSE To evaluate teprotumumab safety/efficacy in patients with thyroid eye disease (TED) who were nonresponsive or who experienced a disease flare. DESIGN The Treatment of Graves' Orbitopathy to Reduce Proptosis with Teprotumumab Infusions in an Open-Label Clinical Extension Study (OPTIC-X) is a teprotumumab treatment and re-treatment trial following the placebo-controlled teprotumumab Phase 3 Treatment of Graves' Orbitopathy (Thyroid Eye Disease) to Reduce Proptosis with Teprotumumab Infusions in a Randomized, Placebo-Controlled, Clinical Study (OPTIC) trial. PARTICIPANTS Patients who previously received placebo (n = 37) or teprotumumab (n = 14) in OPTIC. METHODS OPTIC nonresponders or …

DiplopiaMild hearing impairmentmedicine.medical_specialtygenetic structuresbusiness.industryEye diseaseThyroidmedicine.diseasePlaceboeye diseasesDisease courseSurgeryOphthalmologymedicine.anatomical_structureSafety riskmedicineIn patientmedicine.symptombusinessOphthalmology
researchProduct

Mucocele of the dorsal surface of the tongue : a case report

2018

Mucoceles represent one of the most common lesions of the oral cavity, developing as a result of saliva accumulation. The most frequent affected area is the lower lip, followed by floor of mouth, ventral tongue and buccal mucosa. Despite numerous reports of mucoceles originating on the ventral surface of the tongue, only scarce cases of such a lesion identified on the dorsal tongue surface have been described. In this report a mucocele developed on the dorsal tongue of a 74-year-old woman is described. Additionally a review of previously published mucoceles of the dorsal surface of the tongue is provided and discussed. A 74-year-old female patient was referred for a painless swelling on the…

DorsumGranular cell tumorOral Medicine and Pathologymedicine.diagnostic_testbusiness.industryConnective tissueCase Report030206 dentistryAnatomyLingual Thyroid Glandmedicine.disease:CIENCIAS MÉDICAS [UNESCO]Lesion03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureTongue030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASBiopsymedicineMucocelemedicine.symptombusinessGeneral Dentistry
researchProduct

Teprotumumab for the treatment of active thyroid eye disease

2020

Abstract Background Thyroid eye disease is a debilitating, disfiguring, and potentially blinding periocular condition for which no Food and Drug Administration–approved medical therapy is available...

Drugmedicine.medical_specialtyBlindingmedia_common.quotation_subjectEye diseaseMedizin030204 cardiovascular system & hematologylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawOphthalmologymedicine030212 general & internal medicinemedia_commonTeprotumumabbusiness.industryThyroidGeneral Medicinemedicine.diseaseDermatologyeye diseasesClinical trialmedicine.anatomical_structuresense organsbusinessMedical therapymedicine.drug
researchProduct

Elektronenmikroskopische Untersuchungen zur Capillarhyper�mie in der stimulierten Goldhamsterschilddr�se

1966

Untersuchungen an 32 kalte- bzw. thyreotropinaktivierten Goldhamsterschilddrusen unter Vergleich mit den Glanduale thyreoideae 8 normaktiver Tiere ergaben: 1. Mit einsetzender Kolloidmobilisation werden oberhalb der lichtoptisch erkennbaren Basalmembran der Follikel gelegene, intraepitheliale Capillaren entfaltet. 2. Am Endothel dieser intraepithelialen Capillaren treten hierbei breitere Poren auf, die jedoch durch ein Diaphragma verschlossen bleiben (Endothelfenster). Anscheinend erfolgt ferner ein cytopemptischer Transport von Material aus dem erweiterten periendothelialen Spalt in Richtung Saftestrom. 3. In der Nachbarschaft aktivierter Thyreocyten, insbesondere wenn letztere Anzeichen e…

Embryologymedicine.anatomical_structureChemistryThyroidmedicineCell BiologyAnatomyElectron microscopicMolecular biologyDevelopmental BiologyGolden hamsterZeitschrift f�r Anatomie und Entwicklungsgeschichte
researchProduct

T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma.

2007

T cell functional differentiation is mediated by lineage-specific transcription factors. T helper 17 (Th17) has been recently identified as a distinct Th lineage mediating tissue inflammation. Retinoic acid receptor-related orphan receptor gamma (ROR gamma) was shown to regulate Th17 differentiation; ROR gamma deficiency, however, did not completely abolish Th17 cytokine expression. Here, we report Th17 cells highly expressed another related nuclear receptor, ROR alpha, induced by transforming growth factor-beta and interleukin-6 (IL-6), which is dependent on signal transducer and activator of transcription 3. Overexpression of ROR alpha promoted Th17 differentiation, possibly through the c…

Encephalomyelitis Autoimmune ExperimentalReceptors Retinoic AcidT cellImmunologyRetinoic acidReceptors Cytoplasmic and NuclearElectrophoretic Mobility Shift AssayBiology03 medical and health scienceschemistry.chemical_compoundMice0302 clinical medicineT-Lymphocyte SubsetsmedicineT helper 17 cellImmunology and AllergyAnimalsCell LineageReceptorMOLIMMUNOTranscription factor030304 developmental biologyOrphan receptor0303 health sciencesReceptors Thyroid HormoneReverse Transcriptase Polymerase Chain ReactionInterleukin-17Cell DifferentiationNuclear Receptor Subfamily 1 Group F Member 1T-Lymphocytes Helper-InducerNuclear Receptor Subfamily 1 Group F Member 3Molecular biologyMice Mutant StrainsCell biologymedicine.anatomical_structureInfectious DiseaseschemistryNuclear receptorSTAT proteinTrans-ActivatorsFemale030215 immunologyImmunity
researchProduct

Analytical Performance and Validation of a Bioassay for Thyroid-Blocking Antibodies

2016

A cell-based bioassay for the measurement of thyroid blocking autoantibodies (TBAb) has been recently reported. The analytical performance and validation of this bioassay is assessed and described.Chinese hamster ovary cells expressing a chimeric thyrotropin receptor were treated with bovine (b) TSH and different concentrations of an immunoglobulin G (IgG) monoclonal human TBAb (K1-70). TBAb was measured as a function of luciferase activity relative to bTSH alone and expressed as percent inhibition. Results obtained in the chimeric cell line were compared with those of a wild-type cell line. Analytical performance studies were subsequently performed with the chimeric cell line only.Immunode…

Endocrinology Diabetes and MetabolismThyroid Gland030209 endocrinology & metabolismCHO CellsImmunoglobulin GThyrotropin receptor03 medical and health sciencesCricetulus0302 clinical medicineEndocrinologyBlocking antibodyAnimalsHumansBioassayAntibodies BlockingAutoantibodiesDetection limitbiologyChemistryChinese hamster ovary cellReproducibility of ResultsMolecular biologyImmunoglobulin G030220 oncology & carcinogenesisMonoclonalbiology.proteinBiological AssayAntibodyImmunoglobulins Thyroid-StimulatingThyroid
researchProduct

The Daily Consumption of Cola Can Determine Hypocalcemia: A Case Report of Postsurgical Hypoparathyroidism-Related Hypocalcemia Refractory to Supplem…

2017

The consumption of soft drinks is a crucial factor in determining persistent hypocalcemia. The aim of the study is to evaluate the biochemical mechanisms inducing hypocalcemia in a female patient with usual high consumption of cola drink and persistent hypocalcemia, who failed to respond to high doses of calcium and calcitriol supplementation. At baseline and after pentagastrin injection, gastric secretion (Gs) and duodenal secretion (Ds) samples were collected and calcium and total phosphorus (Ptot) concentrations were evaluated. At the same time, blood calcium, Ptot, sodium, potassium, chloride, magnesium concentrations, and vitamin D were sampled. After intake of cola (1 L) over 180 min,…

Endocrinologyhypoparathyroidismcolahypocalcemiahyperphosphatemiacalcium absorptionFrontiers in Endocrinology
researchProduct

SP619The effect of etelcalcetide in hemodialysis patients with secondary hyperparathyroidism in daily clinical practice. A prospective multicenter st…

2019

EtelcalcetideTransplantationPediatricsmedicine.medical_specialtybusiness.industrymedicine.medical_treatmentmedicine.diseaseClinical PracticeMulticenter studyNephrologymedicineSecondary hyperparathyroidismHemodialysisbusinessNephrology Dialysis Transplantation
researchProduct